Skip to main content
Erschienen in: Urolithiasis 5/2019

12.02.2019 | Original Paper

A preliminary study: the role of preoperative procalcitonin in predicting postoperative fever after mini-percutaneous nephrolithotomy in patients with a negative baseline urine culture

verfasst von: Deng Li, Minglei Sha, Lei Chen, Yinglong Xiao, Jun Lu, Yi Shao

Erschienen in: Urolithiasis | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

To evaluate the role of preoperative procalcitonin (PCT) levels in predicting postoperative fever after mini-percutaneous nephrolithotomy (mini-PCNL) in patients with a negative baseline urine culture. Between January 2014 and October 2017, 329 patients with a negative baseline urine culture and who underwent mini-PCNL were enrolled in this study. Patients were stratified into the control or febrile group based on a body temperature either less than or greater than 38 °C, respectively. Demographic and perioperative data were compared between the groups, and variables found to be statistically significant were included in a binary logistic regression analysis. A total of 68 (20.6%) patients experienced postoperative fever. The univariate analysis revealed a statistically significant difference between groups in preoperative fever (p = 0.032), stone burden (p < 0.001), C-reactive protein (p = 0.011), PCT (p < 0.001) and interleukin-6 (p = 0.035) levels. Binary logistic regression analysis indicated that stone burden > 353 mm3 (p = 0.003) and PCT > 0.05 ng/mL (p < 0.001) are independent risk factors for postoperative fever in mini-PCNL-treated patients with a negative baseline urine culture. We concluded that patients with stone burden > 353 mm3 or PCT > 0.05 ng/mL were more likely to develop postoperative fever after mini-PCNL, though with a negative baseline urine culture.
Literatur
1.
Zurück zum Zitat Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899–906CrossRef Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899–906CrossRef
2.
Zurück zum Zitat Viers BR, Cockerill PA, Mehta RA, Bergstralh EJ, Krambeck AE (2014) Extended antimicrobial use in patients undergoing percutaneous nephrolithotomy and associated antibiotic related complications. J Urol 192:1667–1672CrossRef Viers BR, Cockerill PA, Mehta RA, Bergstralh EJ, Krambeck AE (2014) Extended antimicrobial use in patients undergoing percutaneous nephrolithotomy and associated antibiotic related complications. J Urol 192:1667–1672CrossRef
3.
Zurück zum Zitat Wagenlehner FM, Lichtenstern C, Rolfes C, Mayer K, Uhle F, Weidner W, Weigand MA (2013) Diagnosis and management for urosepsis. Int J Urol 20:963–970PubMed Wagenlehner FM, Lichtenstern C, Rolfes C, Mayer K, Uhle F, Weidner W, Weigand MA (2013) Diagnosis and management for urosepsis. Int J Urol 20:963–970PubMed
4.
Zurück zum Zitat Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14:R15CrossRef Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14:R15CrossRef
5.
Zurück zum Zitat Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610–1614CrossRef Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610–1614CrossRef
6.
Zurück zum Zitat Knudsen JB, Fuursted K, Petersen E, Wierup P, Mølgaard H, Poulsen SH, Egeblad H (2010) Procalcitonin in 759 patients clinically suspected of infective endocarditis. Am J Med 123:1121–1127CrossRef Knudsen JB, Fuursted K, Petersen E, Wierup P, Mølgaard H, Poulsen SH, Egeblad H (2010) Procalcitonin in 759 patients clinically suspected of infective endocarditis. Am J Med 123:1121–1127CrossRef
7.
Zurück zum Zitat Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P, ProHOSP Study Group (2010) Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest 138:121–129CrossRef Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P, ProHOSP Study Group (2010) Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest 138:121–129CrossRef
8.
Zurück zum Zitat van Nieuwkoop C, Bonten TN, van’t Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, van Dissel JT (2010) Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 14:R206CrossRef van Nieuwkoop C, Bonten TN, van’t Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, van Dissel JT (2010) Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 14:R206CrossRef
9.
Zurück zum Zitat Druskin SC, Ziemba JB (2016) Minimally invasive (“Mini”) percutaneous nephrolithotomy: classification, indications, and outcomes. Curr Urol Rep 17:30CrossRef Druskin SC, Ziemba JB (2016) Minimally invasive (“Mini”) percutaneous nephrolithotomy: classification, indications, and outcomes. Curr Urol Rep 17:30CrossRef
10.
Zurück zum Zitat Procalcitonin Emergency Clinical Application of Expert Consensus Group (2012) Expert consensus on clinical application of procalcitonin (PCT) in emergency. Chin J Emerg Med 9:944–951 Procalcitonin Emergency Clinical Application of Expert Consensus Group (2012) Expert consensus on clinical application of procalcitonin (PCT) in emergency. Chin J Emerg Med 9:944–951
11.
Zurück zum Zitat Tiselius HG, Andersson A (2003) Stone burden in an average Swedish population of stone formers requiring active stone removal: how can the stone size be estimated in the clinical routine? Eur Urol 43:275–281CrossRef Tiselius HG, Andersson A (2003) Stone burden in an average Swedish population of stone formers requiring active stone removal: how can the stone size be estimated in the clinical routine? Eur Urol 43:275–281CrossRef
12.
Zurück zum Zitat Labate G, Modi P, Timoney A, Cormio L, Zhang X, Louie M, Grabe M, Rosette On Behalf Of The Croes Pcnl Study Group J (2011) The percutaneous nephrolithotomy global study: classification of complications. J Endourol 25:1275–1280CrossRef Labate G, Modi P, Timoney A, Cormio L, Zhang X, Louie M, Grabe M, Rosette On Behalf Of The Croes Pcnl Study Group J (2011) The percutaneous nephrolithotomy global study: classification of complications. J Endourol 25:1275–1280CrossRef
13.
Zurück zum Zitat Gravas S, Montanari E, Geavlete P, Onal B, Skolarikos A, Pearle M, Sun YH, de la Rosette J (2012) Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J Urol 188:843–847CrossRef Gravas S, Montanari E, Geavlete P, Onal B, Skolarikos A, Pearle M, Sun YH, de la Rosette J (2012) Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J Urol 188:843–847CrossRef
14.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef
15.
Zurück zum Zitat Zeng G, Mai Z, Zhao Z, Li X, Zhong W, Yuan J, Wu K, Wu W (2013) Treatment of upper urinary calculi with Chinese minimally invasive percutaneous nephrolithotomy: a single-center experience with 12,482 consecutive patients over 20 years. Urolithiasis 41:225–229CrossRef Zeng G, Mai Z, Zhao Z, Li X, Zhong W, Yuan J, Wu K, Wu W (2013) Treatment of upper urinary calculi with Chinese minimally invasive percutaneous nephrolithotomy: a single-center experience with 12,482 consecutive patients over 20 years. Urolithiasis 41:225–229CrossRef
16.
Zurück zum Zitat Kreydin EI, Eisner BH (2013) Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol 10:598–605CrossRef Kreydin EI, Eisner BH (2013) Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol 10:598–605CrossRef
17.
Zurück zum Zitat Fowler JE Jr (1984) Bacteriology of branched renal calculi and accompanying urinary tract infection. J Urol 131:213–215CrossRef Fowler JE Jr (1984) Bacteriology of branched renal calculi and accompanying urinary tract infection. J Urol 131:213–215CrossRef
18.
Zurück zum Zitat Sridharan P, Chamberlain RS (2013) The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? Surg Infect (Larchmt) 14:489–511CrossRef Sridharan P, Chamberlain RS (2013) The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? Surg Infect (Larchmt) 14:489–511CrossRef
19.
Zurück zum Zitat Bozza FA, Bozza PT, Castro Faria Neto HC (2005) Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity? Mem Inst Oswaldo Cruz 100(Suppl 1):217–221CrossRef Bozza FA, Bozza PT, Castro Faria Neto HC (2005) Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity? Mem Inst Oswaldo Cruz 100(Suppl 1):217–221CrossRef
20.
Zurück zum Zitat Liu HH, Guo JB, Geng Y, Su L (2015) Procalcitonin: present and future. Ir J Med Sci 184:597–605CrossRef Liu HH, Guo JB, Geng Y, Su L (2015) Procalcitonin: present and future. Ir J Med Sci 184:597–605CrossRef
21.
Zurück zum Zitat Anand D, Das S, Bhargava S, Srivastava LM, Garg A, Tyagi N, Taneja S, Ray S (2015) Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. J Crit Care 30:218.e7–218.e12CrossRef Anand D, Das S, Bhargava S, Srivastava LM, Garg A, Tyagi N, Taneja S, Ray S (2015) Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. J Crit Care 30:218.e7–218.e12CrossRef
22.
Zurück zum Zitat Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Müller B (2004) Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 32:1715–1721CrossRef Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Müller B (2004) Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 32:1715–1721CrossRef
23.
Zurück zum Zitat Gonsalves MD, Sakr Y (2010) Early identification of sepsis. Curr Infect Dis Rep 12:329–335CrossRef Gonsalves MD, Sakr Y (2010) Early identification of sepsis. Curr Infect Dis Rep 12:329–335CrossRef
24.
Zurück zum Zitat Zheng J, Li Q, Fu W, Ren J, Song S, Deng G, Yao J, Wang Y, Li W, Yan J (2015) Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy. Urolithiasis 43:41–47CrossRef Zheng J, Li Q, Fu W, Ren J, Song S, Deng G, Yao J, Wang Y, Li W, Yan J (2015) Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy. Urolithiasis 43:41–47CrossRef
25.
Zurück zum Zitat Pantelidou IM, Giamarellos-Bourboulis EJ (2015) Can procalcitonin monitoring reduce the length of antibiotic treatment in bloodstream infections? Int J Antimicrob Agents 46(Suppl 1):S10–S12CrossRef Pantelidou IM, Giamarellos-Bourboulis EJ (2015) Can procalcitonin monitoring reduce the length of antibiotic treatment in bloodstream infections? Int J Antimicrob Agents 46(Suppl 1):S10–S12CrossRef
26.
Zurück zum Zitat Dreger NM, Degener S, Ahmad-Nejad P, Wöbker G, Roth S (2015) Urosepsis-etiology, diagnosis, and treatment. Dtsch Arztebl Int 112:837–847PubMedPubMedCentral Dreger NM, Degener S, Ahmad-Nejad P, Wöbker G, Roth S (2015) Urosepsis-etiology, diagnosis, and treatment. Dtsch Arztebl Int 112:837–847PubMedPubMedCentral
Metadaten
Titel
A preliminary study: the role of preoperative procalcitonin in predicting postoperative fever after mini-percutaneous nephrolithotomy in patients with a negative baseline urine culture
verfasst von
Deng Li
Minglei Sha
Lei Chen
Yinglong Xiao
Jun Lu
Yi Shao
Publikationsdatum
12.02.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 5/2019
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-019-01115-3

Weitere Artikel der Ausgabe 5/2019

Urolithiasis 5/2019 Zur Ausgabe

Männern mit Zystitis Schmalband-Antibiotika verordnen

03.05.2024 Zystitis Nachrichten

Die akute Zystitis von Männern und ihre Therapie sind wenig erforscht. Norwegische Forscher haben das nachgeholt. Ihr Rat: Erst einmal keine Breitbandantibiotika verordnen.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

D-Mannose ohne Nutzen in der Prävention von HWI-Rezidiven

D-Mannose, eine Hoffnungsträgerin in der Rezidivprophylaxe von Harnwegsinfektionen, hat in einer Studie nicht mehr bewirken können als ein Placebo. Die Empfehlung zur Einnahme entfalle damit, so die Autoren.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.